Learn More
Selleck Chemical LLC Entinostat (MS-275) 200mg 209783-80-2 SNDX-275

Supplier: Selleck Chemical LLC S1053200MG

Entinostat (MS-275, SNDX-275) strongly inhibits HDAC1 and HDAC3 with IC50 of 0.51 ?M and 1.7 ?M in cell-free assays, compared with HDACs 4, 6, 8, and 10. Entinostat induces autophagy and apoptosis. Phase 3. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.